Chugai Pharmaceutical
(OTC) CHGCF
Chugai Pharmaceutical Financials at a Glance
Market Cap
$85.48B
Revenue (TTM)
$1.26T
Net Income (TTM)
$435.71B
EPS (TTM)
$1.76
P/E Ratio
29.50
Dividend
$0.81
Beta (Volatility)
0.14 (Low)
Dividend
$0.81
Beta (Volatility)
0.14 (Low)
Price
$51.94
Volume
888
Open
$52.78
Price
$51.94
Volume
888
Open
$52.78
Previous Close
$51.94
Daily Range
$51.94 - $52.78
52-Week Range
$38.01 - $70.91
Dividend
$0.81
Beta (Volatility)
0.14 (Low)
Price
$51.94
Volume
888
Open
$52.78
Previous Close
$51.94
Daily Range
$51.94 - $52.78
52-Week Range
$38.01 - $70.91
CHGCF News
CHGCF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Chugai Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
7,778
CEO
Osamu Okuda
Website
www.chugai-pharm.co.jpHeadquarters
Chuo, 103-8324, JP
CHGCF Financials
Key Financial Metrics (TTM)
Gross Margin
71%
Operating Margin
47%
Net Income Margin
35%
Return on Equity
23%
Return on Capital
29%
Return on Assets
18%
Earnings Yield
3.39%
Dividend Yield
0.02%
Payout Ratio
68.99%
Stock Overview
Market Cap
$85.48B
Shares Outstanding
1.65B
Volume
888
Short Interest
0.00%
Avg. Volume
1.32K
Financials (TTM)
Gross Profit
$895.03B
Operating Income
$590.71B
EBITDA
$631.92B
Operating Cash Flow
$389.79B
Capital Expenditure
$76.34B
Free Cash Flow
$313.45B
Cash & ST Invst.
$980.55B
Total Debt
$0.00
Chugai Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$346.60B
+14.7%
Gross Profit
$258.97B
+24.6%
Gross Margin
74.72%
N/A
Market Cap
$85.48B
N/A
Market Cap/Employee
$17.01M
N/A
Employees
5,026
N/A
Net Income
$128.52B
+40.4%
EBITDA
$179.33B
+16.6%
Quarterly Fundamentals
Net Cash
$980.55B
-0.5%
Accounts Receivable
$443.50B
+32.7%
Inventory
$277.09B
+15.4%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
17.58%
N/A
Return on Invested Capital
28.68%
N/A
Free Cash Flow
$112.77B
-26.1%
Operating Cash Flow
$130.16B
-14.6%